FAIM
EDIT icon

Financial Advocates Investment Management’s Editas Medicine EDIT Stock Holding History

Financial Advocates Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,882
Closed -$943K – 790
2022
Q3 		$943K Buy
+7,882
New +$123K 0.08% 262
2020
Q4 		– Sell
-11,000
Closed -$309K – 724
2020
Q3 		$309K Sell
11,000
-400
-4% -$13K 0.03% 472
2020
Q2 		$337K Sell
11,400
-390
-3% -$10.2K 0.03% 441
2020
Q1 		$234K Sell
11,790
-615
-5% -$15.5K 0.03% 405
2019
Q4 		$367K Sell
12,405
-385
-3% -$9.62K 0.04% 368
2019
Q3 		$291K Sell
12,790
-696
-5% -$17.2K 0.03% 382
2019
Q2 		$334K Sell
13,486
-14
-0.1% -$334 0.04% 357
2019
Q1 		$330K Buy
13,500
+250
+2% +$5.66K 0.04% 346
2018
Q4 		$301K Buy
13,250
+571
+5% +$15.5K 0.04% 336
2018
Q3 		$403K Buy
12,679
+504
+4% +$16.3K 0.05% 324
2018
Q2 		$450K Buy
+12,175
New +$431K 0.05% 280
2018
Q1 		– Sell
-10,700
Closed -$319K – 496
2017
Q4 		$319K Buy
+10,700
New +$269K 0.04% 345

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Financial Advocates Investment Management's EDIT Position: Q4 2022 in Review

Financial Advocates Investment Management sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 7,882 shares — an estimated $943K sold.

Financial Advocates Investment Management first reported a position in EDIT in Q4 2017 and held it in 12 quarters. The position peaked at $943K in Q3 2022. 251 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Financial Advocates Investment Management reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Financial Advocates Investment Management sold 7,882 Editas Medicine shares in Q4 2022, an estimated $943K.
  • Financial Advocates Investment Management first reported a position in Editas Medicine in Q4 2017 and held it in 12 quarters.
  • Financial Advocates Investment Management's Editas Medicine position peaked at $943K in Q3 2022.
  • 251 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Financial Advocates Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.